Home Cart 0 Sign in  
X

[ CAS No. 147403-03-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 147403-03-0
Chemical Structure| 147403-03-0
Chemical Structure| 147403-03-0
Structure of 147403-03-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 147403-03-0 ]

Related Doc. of [ 147403-03-0 ]

Alternatived Products of [ 147403-03-0 ]

Product Details of [ 147403-03-0 ]

CAS No. :147403-03-0 MDL No. :MFCD20278186
Formula : C25H20N4O5 Boiling Point : -
Linear Structure Formula :- InChI Key :KGSXMPPBFPAXLY-UHFFFAOYSA-N
M.W : 456.45 Pubchem ID :135415867
Synonyms :
TAK-536
Chemical Name :2-Ethoxy-1-((2'-(5-oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylic acid

Calculated chemistry of [ 147403-03-0 ]

Physicochemical Properties

Num. heavy atoms : 34
Num. arom. heavy atoms : 26
Fraction Csp3 : 0.12
Num. rotatable bonds : 7
Num. H-bond acceptors : 7.0
Num. H-bond donors : 2.0
Molar Refractivity : 125.29
TPSA : 123.24 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.99 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.48
Log Po/w (XLOGP3) : 4.36
Log Po/w (WLOGP) : 4.19
Log Po/w (MLOGP) : 3.11
Log Po/w (SILICOS-IT) : 4.19
Consensus Log Po/w : 3.67

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -5.52
Solubility : 0.00138 mg/ml ; 0.00000302 mol/l
Class : Moderately soluble
Log S (Ali) : -6.66
Solubility : 0.000099 mg/ml ; 0.000000217 mol/l
Class : Poorly soluble
Log S (SILICOS-IT) : -8.19
Solubility : 0.00000293 mg/ml ; 0.0000000064 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 2.0
Synthetic accessibility : 3.55

Safety of [ 147403-03-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P501-P273-P202-P201-P280-P308+P313-P405 UN#:N/A
Hazard Statements:H361-H413 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 147403-03-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 147403-03-0 ]
  • Downstream synthetic route of [ 147403-03-0 ]

[ 147403-03-0 ] Synthesis Path-Upstream   1~2

  • 1
  • [ 1403477-45-1 ]
  • [ 147403-65-4 ]
  • [ 147403-03-0 ]
YieldReaction ConditionsOperation in experiment
74.8 %Chromat. With potassium <i>tert</i>-butylate In 1-methyl-pyrrolidin-2-one at 20℃; for 4 h; Example 4 Methyl 2-ethoxy- 1 -((2'-(5-oxo-4,5-dihydro- 1 ,2,4-oxadiazol-3 -yl)biphenyl-4-yl)methyl)- 1 H- benzo[<i]imidazole-7-carboxylate of formula la0.05 g of the corresponding base was added to a mixture of 0.2 g of methyl 2-ethoxy- 1 -((2'- (A^-(methoxycarbonyloxy)carbamimidoyl)biphenyl-4-yl)methyl)-lH-benz[if]imidazole-7- carboxylate (of formula Vlaa; R' = Me) and 4 ml of the respective solvent, stirred in a reaction vial, and the mixture was stirred at the room temperature for 4 h. The collected samples were acidified with acetic acid and analyzed with HPLC. The results are summarized in Table I. Table I - Yield and purity of the product of Example 4
Reference: [1] Patent: WO2012/139535, 2012, A1, . Location in patent: Page/Page column 12-13
  • 2
  • [ 1403474-75-8 ]
  • [ 1403474-70-3 ]
  • [ 147403-03-0 ]
YieldReaction ConditionsOperation in experiment
39.3 %Chromat. With sodium ethanolate In dimethyl sulfoxide at 20℃; for 4 h; Example 5Ethyl 2-ethoxy- 1 -((2'-(5-oxo-4,5-dihydro- 1 ,2,4-oxadiazol-3-yl)biphenyl-4-yl)methyl)- 1 H- benzo[c ]imidazole-7-carboxylate of formula lb0.05 g of the corresponding base was added to a mixture of 0.2 g of ethyl 2-ethoxy- l -((2'-(N'- (ethoxycarbonyloxy)carbamimidoyl)biphenyl-4-yl)methyl)- l -benz[(i]imidazole-7- carboxylate (of formula VIbb; R' = Et) and 4 ml of the respective solvent, stirred in a reaction vial, and the mixture was stirred at the room temperature for 4 h. The collected samples were acidified with acetic acid and analyzed with HPLC. Table II - Yield and purity of the product of Example 5
Reference: [1] Patent: WO2012/139535, 2012, A1, . Location in patent: Page/Page column 13-14
Same Skeleton Products
Historical Records

Similar Product of
[ 147403-03-0 ]

Chemical Structure| 1346599-45-8

A724753[ 1346599-45-8 ]

Azilsartan D5

Reason: Stable Isotope